Aytu Biopharma (AYTU) Inventory Average (2016 - 2025)
Aytu Biopharma (AYTU) has disclosed Inventory Average for 11 consecutive years, with $9.4 million as the latest value for Q4 2025.
- Quarterly Inventory Average fell 17.82% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, down 17.82% year-over-year, with the annual reading at $11.8 million for FY2025, 2.32% down from the prior year.
- Inventory Average for Q4 2025 was $9.4 million at Aytu Biopharma, down from $10.8 million in the prior quarter.
- The five-year high for Inventory Average was $16.4 million in Q4 2021, with the low at $9.4 million in Q4 2025.
- Average Inventory Average over 5 years is $12.7 million, with a median of $12.6 million recorded in 2023.
- The sharpest move saw Inventory Average soared 82.11% in 2021, then fell 27.36% in 2022.
- Over 5 years, Inventory Average stood at $16.4 million in 2021, then decreased by 21.45% to $12.9 million in 2022, then increased by 0.57% to $13.0 million in 2023, then dropped by 12.1% to $11.4 million in 2024, then decreased by 17.82% to $9.4 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods came in at $9.4 million, $10.8 million, and $11.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.